# Higher vs. Lower Dose Heparin for PCI

> **NCT04049591** · NA · RECRUITING · sponsor: **Population Health Research Institute** · enrollment: 16000 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Higher Dose UFH
- **DRUG:** Lower Dose UFH

## Key facts

- **NCT ID:** NCT04049591
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-02
- **Primary completion:** 2024-10-08
- **Final completion:** 2025-12
- **Target enrollment:** 16000 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04049591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04049591, "Higher vs. Lower Dose Heparin for PCI". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04049591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*